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Mutation, irregular expression and sustained activation of the Transient Receptor Potential Channel, 
type Melastatin 4 (TRPM4), have been linked to various cardiovascular diseases. However, much 
remains unknown about the structure of this important ion channel. Here, we have purified a 
heterologously expressed TRPM4-eGFP fusion protein and investigated the oligomeric state of TRPM4-
eGFP in detergent micelles using crosslinking, native gel electrophoresis, multi-angle laser light 
scattering and electron microscopy. Our data indicate that TRPM4 is tetrameric, like other TRP channels 
studied to date. Furthermore, the functionality of liposome reconstituted TRPM4-eGFP was examined 
using electrophysiology. Single-channel recordings from TRPM4-eGFP proteoliposomes showed 
inhibition of the channel using Flufenamic acid, a well-established inhibitor of TRPM4, suggesting that 
the channels are functional upon reconstitution. Our characterisation of the oligomeric structure of 
TRPM4 and the ability to reconstitute functional channels in liposomes should facilitate future studies 
into the structure, function and pharmacology of this therapeutically relevant channel.
Ischaemic heart disease is currently the most common cause of mortality worldwide1,2. There is a pressing need 
for more effective pharmaceuticals and/or interventions to limit damage to the myocardium caused by reperfu-
sion injury in patients with ischemic heart disease1–3. Recent studies in rodent models have shown that inhibition 
of TRPM4 abolished arrhythmias caused by ventricular hypoxia and re-oxygenation-induced early after depolar-
izations (EADs), or protected hearts subjected to global ischemia-reperfusion injury, where contractile function 
recovered significantly and infarct volume decreased1,4. Previous studies have also shown that 18 mutations in 
the TRPM4 gene are each linked to cardiac conduction disorders including progressive familial heart block type 
1, isolated cardiac conduction disease, bifascicular block, atrio-ventricular conduction block and right bundle 
branch block5–9, indicating that this channel is critically involved in cardiac conduction7–9.
Cardiac conduction is closely related to mechano-electric feedback, which modulates heart rate10, and mech-
anosensitive ion channels detect mechanical stimuli such as atrial stretch11. Stretch of cardiac tissue can result in 
change of the shape and duration of action potentials, which in turn can lead to arrhythmogenesis11. TRPM4 has 
been suggested to function as a mechanosensitive channel12–16, but activation of TRPM4 by membrane stretch 
has only been demonstrated in a single study to date17. Whether TRPM4 is inherently mechanosensitive without 
the involvement of intermediate proteins or other cellular structures is currently unknown. The fact that multiple 
studies implicate TRPM4 as a potential pharmacological target for the treatment of heart failure and other cardi-
ovascular diseases4–6,18,19 highlight the importance of obtaining a detailed understanding of TRPM4 structure and 
function (including confirmation of its mechanosensitivity).
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The transmembrane domains of TRPM4 share high sequence similarity with those of other TRP channels20, 
and TRPM4 is expected to have a similar structure to the voltage and ligand-gated potassium channel superfam-
ily21–23. Each TRPM4 monomer (or alpha subunit) is comprised of six transmembrane-spanning helical domains 
(S1-S6)24. The sensor region of TRPM4 has been reported to be located in helices S1-S4, and serves to receive and 
transduce signal to the gate that opens or closes the pore5,24. The selectivity pore is located between S5 and S6 and 
spans the lipid membrane, functioning to allow the selective passage of certain ions and/or hydrophilic mole-
cules5,7,13,24. Mutagenesis studies of TRPM4 indicate that residues in the S5-S6 selectivity filter domain are critical 
in determining the conductance and ion selectivity of the channel5,25. The selectivity pore of TRPM4 is formed by 
the association of transmembrane domains from each subunit of the channel protein5,24. Using electron micros-
copy and cryo-electron microscopy, a number of other TRP channels, including TRPV1, TRPV4, TRPA1, TRPC3 
and TRPM2, have been shown to form tetramers26–30. TRPM4 has also been predicted to form tetramers, which 
serve as the functional unit, though this has yet to be confirmed experimentally5. Recent evidence by Clemençon 
et al. 2014 suggests that TRPM4 is tetrameric, based on negative stain electron micrographs displaying low res-
olution particles of different size31. The majority of the projections are of TRPM4 in its monomeric form, while 
larger particles were identified as potential tetramers based on their overall size31. However, further studies are 
required to confirm this finding.
In this study we demonstrate that the supramolecular structure of TRPM4 is tetrameric, using a variety of 
biochemical methods. We also show that the liposome-reconstituted, heterologously expressed channel is func-
tional and behaves similarly to TRPM4 endogenously expressed in human cell lines. Lastly, given that mechano-
sensitivity plays an important role in both normal physiology and cardiovascular diseases, including arrhythmia, 
hypertrophy and ischemia-reperfusion injury11, we also investigated the mechanosensitive properties of TRPM4 
and determined that this channel does not appear to be intrinsically stretch modulated.
Results
TRPM4-eGFP expression and localisation. Expression of full length TRPM4 fused to eGFP was 
confirmed by Western blotting and a 473 nm laser scan of an SDS-PAGE gel. The presence of the FLAG tag, 
8-Histidine tag and the C-terminal TRPM4 sequence was confirmed by Western blotting, which revealed a band 
of approximately 167 kDa in each blot (Fig. S1B–E). The presence of the eGFP tag in the fusion protein was 
confirmed by performing a 473 nm laser scan of the gel. A prominent band was detected at 167 kDa, which is in 
accordance with the expected size of the full-length monomeric protein (Fig. S1D).
Localisation of the expression of the TRPM4-eGFP protein in baculovirus-infected sf9 cells was determined 
using FM4-64 FX membrane staining and confocal microscopy. FM4-64 FX fluoresces strongly when bound to 
the outer leaflet of the plasma membrane and yields discrete plasma membrane staining32. As shown in Fig. S1F, 
expression of TRPM4-eGFP co-localised with the FM4-64 FX dye and is observed within the plasma membrane 
and around the perinuclear region of infected sf9 cells. The expression of the TRPM4-eGFP fusion protein in 
the plasma membrane of sf9 is consistent with previous studies visualising the location of hTRPM4 in human 
cells7,33–35.
hTRPM4-eGFP fusion protein detergent screen. To estimate the size and homogeneity of the 
hTRPM4-eGFP fusion protein after solubilisation in different detergents, detergent-solubilised hTRPM4-eGFP 
samples were subjected to fluorescence size-exclusion chromatography (FSEC). Solubilisation of hTRPM4-eGFP 
with non-ionic detergents such as 1% LMNG, 1% digitonin, 2% DDM and 1% DM yielded mainly oligo-
meric protein, with the presence some of aggregates and degraded products (Figs S2 and S3). Solubilisation of 
hTRPM4-eGFP with 1% fos choline-14 resulted in 80% of the protein maintaining the oligomeric state, which was 
significantly higher than was observed with the other detergents. However, the overall yield of protein solubilised 
was much lower than for other detergents (Fig. S2). Ultimately, solubilisation hTRPM4-eGFP with 1% LMNG, 2% 
DDM or 1% digitonin was found to provide the highest yield of oligomeric protein and thus, TRPM4 was purified 
using mild non-ionic detergents.
TRPM4-eGFP purification. The TRPM4-eGFP fusion protein was isolated under non-denaturing condi-
tions and solubilised in n-dodecyl-β -D-maltopyranoside (DDM) and lauryl maltose neopentyl glycol (LMNG), 
which being mild detergents, are more likely to maintain membrane proteins in a native conformation com-
pared to harsh ionic detergents36. Isolation of TRPM4-eGFP protein using Histidine affinity and size-exclusion 
chromatography yielded a sufficient amount of protein with adequate purity for downstream biochemical and 
biophysical characterisation. The UV and fluorescence chromatograms from the second round of size-exclusion 
purification displayed a large peak at 11-12 mL corresponding to oligomeric TRPM4-eGFP and a small peak at 
8 mL (void volume) which contained aggregated protein (Fig. S4A,C). The protein from the fractions of the large 
peak at 11-12 mL were run on SDS-PAGE and then scanned for GFP fluorescence and/or Coomassie stained. 
The major band observed corresponded to a size of ~167 kDa (Fig. S4B,D). The identity of this band was con-
firmed as hTRPM4 using peptide mass fingerprinting analysis (Mass Spectrometry Core Facility (MCSF), Sydney 
University).
Purification of cleaved TRPM4. After the first round of size-exclusion chromatography, the TRPM4-eGFP 
protein was cleaved with TEV protease to remove the eGFP-8His tag. TRPM4 was then exchanged into amphipol 
A8-35 and subjected to a second round of size-exclusion chromatography. The cleaved protein was dialysed into 
amphipol A8–35 to further stabilise the native protein structure in preparation for imaging by electron micros-
copy. The UV size-exclusion chromatogram of cleaved TRPM4 (without GFP tag) maintained in amphipol A8-35 
contained a single, narrow, symmetrical peak (Fig. S4. E), which suggests that the protein was unlikely to be mis-
folded or aggregated. A fraction corresponding to the peak was analysed using SDS-PAGE and coomassie-stained, 
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which revealed a band of ~137 kDa, indicating that the eGFP-8His tag was successfully cleaved off and that the 
protein was sufficiently pure (Fig. S4. F).
Blue native PAGE. Electrophoresis of TRPM4-eGFP using non-denaturing blue native PAGE resulted in a 
prominent band with a migration distance corresponding to an approximate Mr of 638,000/~638 kDa (Fig. 1A), 
which is ~3.8× the molecular weight of monomeric TRPM4-eGFP (167 kDa), suggesting that the protein is likely 
a tetramer. The addition of G-250 to the native gel is thought to coat the protein with a negative charge, thereby 
enhancing protein resolution, enabling more accurate size estimation. However, the conformation adopted by the 
native protein can cause ~15% error when estimating the expected size37.
Crosslinking. To further confirm the oligomeric structure of TRPM4-eGFP, the channel was crosslinked 
using imidoester crosslinkers, FA or BS3. Imidoester crosslinkers initiate nucleophilic attack of lysine amino 
groups, which enables covalent binding of protein monomers via the crosslinker; however, the crosslinkers only 
bind surface residues that are already in close proximity in the native state38,39. The ability to isolate the same 
oligomeric species using multiple crosslinkers with different spacer arm lengths provides good evidence for pro-
tein subunits being in close proximity, reflective of an oligomeric state39. By increasing the duration of incuba-
tion of FA and BS3 with TRPM4-eGFP, three additional bands to the monomer band were formed. With the 
longest incubation times, TRPM4-eGFP appeared mostly as a single, high molecular weight band (Fig. 1B,C). 
Crosslinking of the TRPM4-eGFP fusion protein with formaldehyde (which has a short spacer arm of 2.3–2.77 Å) 
produced four bands, which are consistent with expected monomeric (167 kDa), dimeric (334 kDa), trimeric 
(501 kDa) and tetrameric (668 kDa) species of the protein (Fig. 1B). Likewise, crosslinking with BS3 which has a 
longer spacer arm (11.4 Å) also yielded bands indicative of the same sized species, which is further evidence that 
hTRPM4-eGFP forms a tetramer (Fig. 1C).
SEC-MALLS of TRPM4-eGFP fusion protein and cleaved TRPM4 protein. To accurately deter-
mine the stoichiometry and molecular weight of the oligomers of TRPM4-eGFP as well as TRPM4 alone, the 
purified proteins were separated by size exclusion chromatography and the sizes of the eluted species were esti-
mated using static light scattering (SEC-LS/UV/RI). The ASTRA analysis of the SEC-LS/UV/RI data for the 
hTRPM4-eGFP and cleaved TRPM4 is shown in Fig. 1D,E respectively. The molecular weights of TRPM-eGFP 
protein and cleaved TRPM4, calculated using the protein-conjugate analysis tool in the ASTRA 6 software, were 
determined to be 644.7 kDa (± 0.336%) and 539.4 kDa (± 1.899%). Given that the sizes of the monomers of the 
TRPM4-eGFP fusion protein and TRPM4 alone are 167 and 137 kDa respectively, the stoichiometry for both 
species is 4 monomers. The values calculated by the ASTRA 6 software are close to the expected values of 668 kDa 
for hTRPM4-eGFP and 548 kDa for free TRPM4, indicating that both proteins form a tetramer. The minor differ-
ence in the molecular weights calculated by the ASTRA software and the expected overall molecular weight for 
tetrameric hTRPM4-eGFP and cleaved hTRPM4 is not unexpected as there is usually over 5% error in determin-
ing the molecular weight of membrane proteins using SEC-MALLS40.
Transmission electron microscopy of the cleaved hTRPM4 protein. Transmission electron micros-
copy was used to further characterise the stoichiometry, overall size, shape and architecture of cleaved (eGFP tag 
free) hTRPM4 protein. The electron microscopy images collected from hTRPM4 show distinct oligomers with 
a diameter of approximately 12 nm, which were observed in a range of orientations (Fig. 1F). The most distinct 
orientation displays a symmetrical “4 leaf clover” shape, suggesting tetrameric packing of the protein subunits 
(Fig. 1F, top panel). The diameter of the oligomeric TRPM4 measured from the particle images ranges from 
11–13 nm. These values are similar to the diameter of the structure of TRPV1, determined using cryo-EM to 
be approximately 11 nm (in diameter) with fourfold symmetry26. The distinct tetrameric structure observed in 
some of the TRPM4 images is very similar to the top-down views of the TRPV1 channel obtained by Liao and 
co-workers (Fig. S5)26. A side-by-side comparison of the raw TEM images of TRPM4 and various class-average 
images of TRPV1 from previous studies26,41 highlights the striking resemblance between TRPV1 and TRPM4 in 
different orientations (Fig. S5) Thus, our electron microscopy data further confirms the data we have obtained 
from native gel electrophoresis, crosslinking and SEC-MALLS, which demonstrate that TRPM4 is tetrameric.
Fluorescence lifetime Imaging (FLIM). Having determined that purified hTRPM4 likely forms a 
tetramer, which suggested that it may be functional, we reconstituted the channel into liposomes in order to inves-
tigate its functional properties. We selected soybean azolectin as the lipid for reconstitution of hTRPM4-eGFP 
as it is a mixture of lipids, which has been frequently used for studies of mechanosensitive channels and that 
allows the protein to select appropriate surrounding annular lipid molecules, which enabled reconstitution of 
the protein into liposomes42. To confirm that hTRPM4-eGFP was successfully reconstituted into the liposomes, 
we used fluorescence lifetime imaging (FLIM). When soybean azolectin is excited by a 488 laser on a confocal 
microscope it appears to be fluorescent43; thus to differentiate between azolectin liposomes and TRPM4-eGFP 
proteoliposomes we used fluorescence lifetime imaging as the lifetime of eGFP is shorter than that of azolectin 
alone. The FLIM data were analyzed in the Phasor plot by selecting clusters of pixels, with different lifetime clus-
ters differentiated by colour selection (Fig. 2A–D). The phasor approach is advantageous because it is a simple way 
to analyse FLIM data and the problems associated with exponential analysis are avoided by providing a graphical 
global view of the processes which influence fluorescence decay at individual pixels44. Since different molecular 
species have a specific phasor, individual molecules may be identified via their location on the phasor plot44. The 
hTRPM4-eGFP protein incorporated into azolectin liposomes/lipid has a phasor position shifted from that of the 
autofluorescence component of azolectin alone, indicating a difference in the fluorescence lifetimes of the two 
species (Fig. 2A,B). Encapsulated eGFP is highlighted by the green cursor on the phasor and its position is high-
lighted in the intensity image. It appears that the hTRPM4-eGFP protein is not evenly distributed throughout the 
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Figure 1. TRPM4 fusion protein forms tetramers. (a) Representative image of purified TRPM4 fusion protein 
(arrow) run on a silver stained native gel. (b) Crosslinking of purified TRPM4 fusion protein with formaldehyde 
(FA); samples were run on a denaturing tris acetate gel. The migration positions of the positions of monomeric 
(1× ), dimeric (2× ), trimeric (3× ) and tetrameric (4× ) species are indicated by arrows. (c) Crosslinking of 
hTRPM4-eGFP with bis-sulfosuccinimidyl suberate (BS3); samples were run on a denaturing tris acetate gel. 
The migration position of the monomeric and various crosslinked species are indicated as in (b). (d) SEC-
MALLS chromatogram of the hTRPM4-eGFP fusion protein; molar mass (g/mol) of the protein was calculated 
from the light scattering, UV and refractive index signals. The black dotted line represents the fitting of the 
molar mass across the three signals. (e) SEC-MALLS chromatogram of cleaved TRPM4 protein, molar mass  
(g/mol) of the protein was calculated from the light scattering, UV and refractive index signals. The black dotted 
line represents the fitting of the molar mass across the three signals. (f) Transmission electron microscopy 
(TEM) images of cleaved hTRPM4-eGFP protein display a 4-fold symmetrical channel protein with a diameter 
of approximately 11–13 nm in the top panel (white scale bar is 10 nm). The middle and bottom panels of 
TEM images display side views of the channels or the electron-lucent pore ringed by protein. Schematic 
representation of the “4-leaf clover” shape and a representative cross-section profile are shown below.
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azolectin lipid where the protein has inserted itself into the membrane in clusters (Fig. 2D). Thus, hTRPM4-eGFP 
was successfully reconstituted into azolectin lipid and liposomes, as indicated by the difference in the lifetimes of 
the two species. This finding provided the justification for further functional characterisation of the fusion protein 
in proteoliposomes, using patch clamp electrophysiology.
Functional properties of hTRPM4-eGFP incorporated into proteoliposomes. To determine 
if purified hTRPM4-eGFP was functional and possessed similar channel properties to TRPM4 overexpressed 
in mammalian cells (HEK293 cells) the activity of the hTRPM4-eGFP incorporated into liposomes was char-
acterised using patch clamp electrophysiology. Under symmetric bath conditions (0.14 M NaCl, 0.005 M KCl) 
the current-voltage (I-V) relationship for the hTRPM4-eGFP channel showed that the single channel current 
was ohmic between –100 mV and + 100 mV, with a slope conductance of approximately 28 ± 1 pS (Fig. 3A,B, 
n = 7). These results indicate that hTRPM4-eGFP had a similar conductance to that of TRPM4 expressed in 
human cell lines45–47. Amplitude histogram analysis and kinetic modelling of the single channel recordings from 
hTRPM4-eGFP in proteoliposomes indicated that the fusion protein has a similar conductance of 24 pS (Fig. 3C) 
and the same number of open and closed states as TRPM4 expressed in HEK293 cells, which has two closed states 
and one open state (Fig. S6B-C)48.
Recordings were also obtained in the presence of 20 μ M flufenamic acid (FFA) to ensure functional selection4. 
The channel activity was inhibited when 20 μ M FFA was added to the bath (Fig. 4A,B) causing the open proba-
bility Po to decrease significantly (Fig. 4C). The fact that the hTRPM4 fusion protein displayed sensitivity to FFA 
indicates that heterologously expressed TRPM4 reconstituted into liposomes is functional and behaves similarly 
to TRPM4 expressed in human cell lines. Since the hTRPM4 fusion protein responded to FFA added to the bath, it 
suggests that the intracellular portion of the channel protein uniformly faces the bath, in line with what has been 
reported for liposome reconstituted mechanosensitive channels MscL and MscS49,50. The efficiency of obtaining 
patches containing functional channels was very low (approximately 1% success rate). This is not surprising given 
that TRPM4 is a large, transmembrane protein with 6 extracellular loops, making it likely that most of the pro-
tein molecules were only partially reconstituted and/or inserted in liposomes which precluded proper channel 
Figure 2. Fluorescence lifetime imaging (FLIM) of TRPM4 fusion protein incorporation into azolectin 
liposomes. (a) Phasor plot showing auto fluorescence phasor. (b) Phasor plot showing combination of 
autofluorescence and eGFP incorporated Phasor. (c) Phasor colour map of azolectin liposomes with no protein 
incorporated. Pixels in the image are colour coded according to the same coloured region of interest (ROI) 
selection in the phasor plot. (d) Fluorescence lifetime Phasor colour map of azolectin liposomes with TRPM4-
eGFP fusion protein incorporated. The eGFP protein localisation is represented by green pixels in the image. 
All FLIM data were collected using time correlated single photon counting, and all phasors are shown in the 1st 
harmonic (n = 6).
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function. A study by Dorr et al. in 2014, used detergent-free isolation of KscA from E.coli using native nanodiscs 
to reconstitute the protein into planar lipid bilayers51. Such an approach may improve the likelihood of recon-
stituting functional TRPM4 in the future given the more favourable lipid environment. Another possible reason 
for the low efficiency in obtaining functional channels is that the incorporation of the protein into liposomes was 
not evenly distributed as shown in Fig. 2D, where the protein inserted in clusters of certain regions of liposomes. 
Therefore, it was challenging using conventional path-clamp electrophysiology equipment to ascertain which 
regions of the liposome the protein had been incorporated into.
Morita et al., 2007 demonstrated that hTRPM4 overexpressed in HEK293 cells exhibited mechanosensitivity 
in cell-attached patches upon application of -20 mmHg stretch17. In this study the purified hTRPM4-eGFP fusion 
protein was reconstituted into azolectin liposomes to determine whether TRPM4 is intrinsically stretch-activated 
Figure 3. Conductive properties of hTRPM4-eGFP. (a) Single channel traces recorded at different voltages 
from an excised inside-out patch. Pipette contained 140 mM NaCl, 5 mM KCl, 10 μM CaCl2 and 5 mM HEPES 
pH 7.5. Vm represents the membrane potential. (b) Current (I)-voltage (V) relationship determined under the 
same ionic conditions as in (a) (n = 7). (c) Amplitude histogram of hTRPM4-eGFP at 100 mV, using the same 
ionic conditions as in (a).
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or mechanosensitive. Purified channels reconstituted into liposomes are a useful models for confirming whether 
a channel protein is intrinsically stretch-modulated due to the absence of other background channels and cellular 
components, which may participate in the transmission of mechanical stimuli. In our study, TRPM4 did not 
appear to be inherently mechanosensitive given that the activity of the channel protein remained unaffected by 
membrane tension despite subjecting the liposome patches to various degrees of membrane stretch (i.e. − 5, − 10 
and − 20 mmHg; Fig. 5A,B) and observing no difference in open probability Po (Fig. 5C). A similar result was also 
observed for the dmPiezo1 channel; Coste and colleagues reconstituted dmPiezo1 into planar bilayers, resulting 
in constitutively active channels37 suggesting that planar bilayers and patches were potentially stretched close to 
the bilayer lytic tension52, making the channels apparently non-responsive to changes in mechanical stress. It is 
possible that the lack of a cytoskeleton, asymmetry of the monolayer lipid composition of the membrane bilayer 
and channel clustering are important for TRPM4 mechanosensitivity, with the absence of all of these factors 
in liposomes accounting for the observed lack of responsiveness to stretch when reconstituted in liposomes53. 
Additionally, it has been shown that TRPM4 couples to mechanosensitive purinergic receptors P2Y4 and P2Y6, 
Figure 4. hTRPM4-eGFP inhibition by Flufenamic acid. (a) Single channel trace of hTRPM4-eGFP recorded 
from an excised inside-out patch. Pipette and bath contained 140 mM NaCl, 5 mM KCl, 10 μM CaCl2 and 5 mM 
HEPES pH 7.5. (b) Single channel trace of hTRPM4-eGFP in the presence of 20 μ M flufenamic acid (FFA). 
Pipette and bath contained the same solution as in (a). (c) Normalised open probability histogram of hTRPM4-
eGFP before and after FFA (20 μ M) addition (n = 5, p < 0.0001).
Figure 5. hTRPM4-eGFP is not affected by membrane stretch. (a) Representative single channel trace 
of hTRPM4-eGFP without stretch applied to the patch. Pipette and bath contained 140 mM NaCl, 5 mM 
KCl, 10 μ M CaCl2 and 5 mM HEPES pH 7.5. (b) Representative single channel trace of hTRPM4-eGFP with 
–10 mmHg stretch applied to the patch. Pipette and bath contained the same solution as in (a). (c) Relative 
open probability histogram of hTRPM4-eGFP under varying amounts of stretch (0, − 5, − 10 and − 20 mmHg) 
(n = 3–4, p > 0.05).
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which modulate TRPM4 activity to mediate pressure-induced depolarisation and myogenic constriction in cer-
ebral parenchymal arterioles54. Future studies should clarify the origin of TRPM4 mechanosensitivity by varying 
the lipid composition in liposomes43, adding amphipatic molecules such as LPC to liposomes55, patching TRPM4 
in cellular blebs56 or including known interacting TRPM4 binding partners such as purinergic receptors, which 
can detect and transmit membrane tension.
Discussion
In this study, we have provided substantial evidence to support the view that TRPM4 forms tetrameric ion chan-
nels, which can be functionally reconstituted into liposomes. Furthermore, our work suggests that TRPM4 chan-
nels are not inherently mechanosensitive, i.e. they cannot by activated by stretching the lipid bilayer alone, but 
may require additional membrane components including cytoskeleton, extracellular matrix and/or interaction 
with other membrane proteins to exhibit mechanosensitivity. In summary, hTRPM4-eGFP was overexpressed in 
sf9 cells, the channel protein was purified and the oligomeric form of the channel protein was determined using 
SEC-MALLS, crosslinking, native gel electrophoresis and TEM. This work is the first to convincingly demonstrate 
that the oligomeric structure of TRPM4 is tetrameric, using a variety of methods. Additionally, the negative stain 
TEM images we have acquired of TRPM4 are the first to display its structure in detail. The electron micrographs 
we have obtained bear significant resemblance to the class average images of TRPV1 derived from TEM and 
cryo-electron microscopy. The elucidation of the oligomeric structure of TRPM4 and the procedure for obtaining 
workable amounts of recombinant TRPM4 reported in this study should facilitate future investigation into the 
structure and function of TRPM4.
Additionally, the procedures described in this study have enabled the functional properties of the 
hTRPM4-eGFP channel to be studied in liposome bilayers. The incorporation of the purified hTRPM4-eGFP 
protein into azolectin liposomes was confirmed using Fluorescence lifetime imaging. Fluorescence lifetime imag-
ing may also be used in future studies to assess whether other fluorescently labelled ion channels are incorporated 
into lipid bilayers or liposomes for liposomal assays or functional studies. The ability to characterise the gating 
properties of purified TRPM4 channels in artificial bilayers should also prove useful in future studies of the 
structure–function relationships and the pharmacology of this ion channel. By varying the bilayer composition, it 
should be possible to obtain detailed information on protein-lipid interactions between TRPM4 and certain types 
of lipids, i.e. their head groups as well as acyl chains. Lipid bilayer variation will also facilitate the determination of 
the effect of lipid ordering on channel gating. To our knowledge this is also the first work to demonstrate success-
ful functional reconstitution of purified TRPM4 protein into exogenous lipid bilayers, which may greatly assist 
the evaluation of future pharmacological agents targeting this therapeutically relevant ion channel.
Materials and Methods
FLAG-hTRPM4-eGFP-8His expression. The human trpM4b sequence was amplified using the sequence 
and ligase independent cloning (SLIC) primers shown below:
htrpM4b Fwd Prim: 5′ -CAGGGGCCCCAAAGGCCTGTGGTGCCGGAGAAGGAG-3′ 
htrpM4b Rev Prim: 5′ -GCTCGTCGACGTAGGCCTGTCTTTGGACCCAGGCAGGTCA-3′ 
The pFBDual FPLR_TEVGFPHIS vector (GeneArt) encoding the proteins indicated (shown in #1, below) was 
digested with Stu I and then purified (Promega PCR clean up kit):
FLAG- < protein of interest > -TEVsite-GFP-8His = 7.3 kb. htrpM4 was cloned into the vector using 
a ligation independent cloning (EcoDry In-fusion reactions, Clontech), method, as described in In-Fusion HD 
EcoDry Cloning kit user manual. Recombinant baculovirus was then generated using the manufacturer’s protocol 
(Bac-to-Bac expression system, Invitrogen). To express the protein, Spodoptera frugiperda (sf9) cells were infected 
with recombinant baculovirus and harvested 72-80 h thereafter. Cells were flash frozen and stored at − 80 °C or 
used immediately. To determine the localisation of the TRPM4-eGFP fusion protein expression, baculovirus 
infected sf9 were co-stained with FM4-46FX lipophylic styryl dye and imaged using a confocal microscope, see 
SI text for details.
Western blotting. Expression of the full length fusion protein was confirmed by Western blotting. 
Membranes were probed with FLAG M2, TRPM4 and His antibodies, see SI Materials and Methods for more 
detail.
Gel fluorescence scan. The presence of the GFP tag on the C-terminus of the protein was confirmed by 
performing a 473 nm laser scan of the gel. Crude lysates of TRPM4-eGFP baculovirus infected sf9 and/or purified 
TRPM4-eGFP fusion protein were mixed with 5× Laemmli loading buffer and then subjected to SDS-PAGE gel 
(TGX 4–12% Bio-Rad) fractionation. Subsequently the gel was scanned using the 473 nm laser line on Fujifilm 
Image Reader FLA-5000 V1.0. The data was processed using Multi Gauge 2.3 software.
Detergent Screen for the TRPM4-eGFP fusion protein. A detergent screen was performed for the 
hTRPM4-eGFP fusion protein, where 5 mL pellets of frozen baculovirus infected cells were solubilised in sev-
eral different detergents including 1% Fos-choline-14, 2% DDM, 1% DM, 1% Lauryl Maltose Neopentyl Glycol 
(LMNG), 1% digitonin and a mixture of 0.5% DDM plus 0.5% LMNG (wt/vol) dissolved in a base buffer con-
taining (40 mM Tris pH 7.5, 150 mM NaCl, 150 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 6 mM β -mercaptoethanol, 
5 mM L-Arginine and 10% glycerol). All cell pellets were solubilised for 2 h at 4 °C with rotation before being 
subjected to fluorescence size-exclusion chromatography (FSEC) to determine the size homogeneity of the pro-
teins after solubilisation (whether they be aggregated, oligomeric or degraded). FSEC was performed on an AKTA 
purifier system (Amersham Biosciences) using a Superose 6 10/300 GL column (GE Healthcare) pre-equilibrated 
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with the base buffer and 0.01% (wt/vol) of the detergent the cell pellet was solubilised in. 1 mL of the solubilised 
material was injected per run onto the Superose 6 column and fractions were collected. Samples from individual 
fractions (80 μ L each) were aliquoted into in a black 96 well microplate (Corning) and scanned for fluorescence 
using a BMG PHERAstar FS multimode plate reader (BMG Labtechnologies, Durham, NC).
TRPM4-eGFP Protein purification. Cells were resuspended in a Buffer containing 1.5% DDM (Anatrace) 
or 0.5% LMNG (Anatrace) and the suspension was dounce homogenised then solubilised for 2 h with rotation at 
4 °C. After solubilisation, cell debris was cleared by low-speed centrifugation (5000 g × 20 min) and the superna-
tant fraction was purified using His-tag affinity and fluorescence size exclusion chromatography (FSEC), see SI 
Materials and Methods for detail. The identity of the TRPM4 sequence was confirmed using MALDI-TOF peptide 
mass fingerprinting (Sydney Proteome Group, Sydney University).
SEC-MALLS. The molecular mass of oligomeric TRPM4-eGFP and cleaved TRPM4 were determined using 
a miniDAWN TREOS three-angle static-light scattering detector and a WYATT refractive index detector (Wyatt 
Technology, Santa Barbara, CA). Size-exclusion purified TRPM4-eGFP (500 μ L) was injected onto the Superose 
6 column (GE Healthcare Life Sciences, pore size 400 Å and protein MW range 5–5000 kDa) pre-equilibrated in 
running buffer A (pH 7.8) containing 0.1% DDM, and eluted at a rate of 0.5 mL/min on the Wyatt SEC-MALLS 
system. Alternatively, size exclusion purified cleaved TRPM4 (500 μ L) in amphipols was injected onto a Superose 
6 column equilibrated in running buffer A without detergent at 0.5 mL/min using the Wyatt SEC-MALLS sys-
tem. Refractive index and light scattering detectors were calibrated following the manufacturer’s guidelines. 
The data were processed and analysed using the protein conjugate template of the ASTRA 6.1.2 software (Wyatt 
Technology). See SI text for more detail.
Native gel electrophoresis. To determine the overall size of hTRPM4-eGFP, the purified fusion protein 
was fractionated on a non-denaturing NativePAGE Novex 3–12% Bis-Tris protein gel (1 mm, 10 well) using the 
Novex NativePAGE Bis-Tris system (Life technologies), as per manufacturer’s protocol. Briefly, the TRPM4-eGFP 
was mixed with NativePAGE sample buffer and NativePAGE 5% G-250 Sample Additive and then fractionated at 
150 V for 2 h. Lastly, the native gel was silver stained using SilverQuest Silver Staining Kit (Invitrogen) according 
to the manufacturer’s protocol.
Formaldehyde and BS3 Crosslinking. TRPM4-eGFP was crosslinked using the imidoester crosslinkers 
formaldehyde (FA, Sigma-Aldrich) and bis-sulfosuccinimidyl suberate (BS3, Thermo Fisher Scientific). Purified 
TRPM4-eGFP protein was incubated with or without 0.2% formaldehyde (FA) at room temperature for varying 
time points (10 min, 20 min and 30 min). Additionally purified TRPM4-eGFP was incubated with or without 
2.6 mM bis-sulfosuccinimidyl suberate (BS3) for different times (2 min, 5 min and 10 min). After incubation 
of the samples with their respective crosslinker for various times, NuPAGE LDS sample buffer and NuPAGE 
Reducing Agent (Invitrogen) were added and mixed. The samples were then denatured at 70 °C for 10 min before 
performing electrophoresis using a 3–8% NuPAGE Tris-Acetate gel under denaturing conditions according to 
manufacturer’s instructions. Gels were imaged using a Fujifilm Image Reader FLA-5000 V1.0 (473 nm laser line) 
and data processed using Multi Gauge V2.3 software.
Electron Microscopy. Carbon-coated 200 mesh copper TEM grids (ProSCiTech, Australia) were rendered 
hydrophilic by exposure to UV light (254 nm) for 30 min and then floated on the surface of a drop of cleaved, 
purified TRPM4 (10 uL at 50 μ g/μ L) for 1 min. Excess sample was removed from the grids by contact with filter 
paper. The grids were then washed by floating briefly on a 10 μ L drop of filtered MilliQ water and blotted dry. 
The samples were negatively stained by floating on a 20 μ L drop of 2% wt/vol uranyl acetate for 2 min, followed 
by filter paper blotting. EM grids were imaged on a Phillips CM120 Biofilter TEM, operating at 120 kV at the 
Australian Centre for Microscopy and Microanalysis, University of Sydney. Images were recorded at a magnifica-
tion of 55,000× using a 1024 × 1024 post column Gatan Imaging Filter (GIF) camera.
Fluorescence Lifetime Imaging. Fluorescence lifetime imaging (FLIM) was used to demonstrate that 
hTRPM4-eGFP was incorporated into azolectin liposomes/lipid, see SI text for the method of protein incorpo-
ration into liposomes. When soybean azolectin is excited by a 488 laser on a confocal microscope it appears to 
be fluorescent43; thus to differentiate between azolectin liposomes and TRPM4-eGFP proteliposomes we used 
fluorescence lifetime imaging since the lifetime of eGFP is shorter than that of azolectin alone. A 10 μ L aliquot 
of rehydrated liposomes was placed in a Fluorodish (WPI, FD35-100) and diluted with 200 μ L buffer containing 
140 mM NaCl, 5 mM KCl, 0.1 mM CaCl2 and 5 mM HEPES, pH 7.5. FLIM images were acquired on a PicoQuant 
MicroTime 200 inverted confocal microscope using a 60× , 1.2-NA water immersion objective at the University 
of NSW Biomedical Imaging Facility (BMIF). Samples were pulsed at 470 nm with a fiber-coupled, pulsed laser 
diode with a pulse width under 200 ps. A single-photon avalanche diode (SPAD, microphoton devices) detected 
signals in the range of 489–532 nm, which was connected to time-correlated single-photon counting (TCSPC) 
electronics (PIcoHarp 300; PicoQuant). FLIM data were analysed by a phasor approach44 as described in SI text, 
using SimFCS software developed at the Laboratory for Fluorescence Dynamics (www.lfd.uci.edu).
Electrophysiology. An aliquot (3 uL) of rehydrated liposomes was added to a patch clamp chamber filled 
with recording solution containing 140 mM NaCl, 5 mM KCl, 10 μ M CaCl2 and 5 mM HEPES pH 7.5. Pipettes 
were made from borosilicate glass (Sigma-Aldrich) and pulled using a micropipette puller (Narashige, Japan) 
to an average resistance of 8-10 MΩ . Both the pipette and bath were loaded with the same recording solution. 
Gigaohm seals were obtained after applying suction with the pipette to a unilamellar blister. Episodic voltage 
ramps were applied from − 100 mV to + 100 mV over 2.5 sec. Single channel events were recorded at + /− 80 mV 
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and + /− 100 mV from excised inside-out patches. After obtaining single channel activity, 20 μ M of FFA, an inhib-
itor of TRPM4 channels, was added to the bath. Stretch was also applied to the membrane patch using a syringe 
to apply suction to the patch pipette. The pressure applied was detected by a pressure monitor (World Precision 
Instruments, WPI) or High Speed Pressure Clamp (ALA Scientific instruments). An AxoPatch 200B amplifier 
(Axon Instruments) was used to amplify currents and data acquired at 5 kHz sampling rate with 2-kHz filtration. 
Data were acquired using pClamp 10.2 software, and then analysed using Clampfit 10.2 (Axon Instruments, 
CA) and QuB version 2.0.0.22 software (University of Buffalo). Statistical significance was determined using an 
unpaired t-test (GraphPad Prism 6 software).
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